首页> Alzheimer's & dementia (Amsterdam, Netherlands)> Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.

Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.

导出 LinkOut

翻译打印收藏纠错

第一作者： Robert F,Hillary

第一单位： Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK.

作者： Robert F,Hillary ^[1] ; Danni A,Gadd ^[1] ; Daniel L,McCartney ^[1] ; Liu,Shi ^[2] ; Archie,Campbell ^[1] ; Rosie M,Walker ^[3] ; Craig W,Ritchie ^[4] ; Ian J,Deary ^[5] ; Kathryn L,Evans ^[1] ; Alejo J,Nevado-Holgado ^[2] ; Caroline,Hayward ^[6] ; David J,Porteous ^[1] ; Andrew M,McIntosh ^[7] ; Simon,Lovestone ^[8] ; Matthew R,Robinson ^[9] ; Riccardo E,Marioni ^[1]

作者单位： Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK. ^[1] Department of Psychiatry University of Oxford Oxford UK. ^[2] Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK.;Centre for Clinical Brain Sciences, Chancellor's Building, 49 Little France Crescent University of Edinburgh Edinburgh UK. ^[3] Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK. ^[4] Lothian Birth Cohorts, Department of Psychology University of Edinburgh Edinburgh UK. ^[5] MRC Human Genetics Unit Institute of Genetics and Cancer University of Edinburgh Edinburgh UK. ^[6] Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK.;Division of Psychiatry, Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK. ^[7] Department of Psychiatry University of Oxford Oxford UK.;Neurodegeneration Johnson and Johnson Medical Ltd Wokingham UK. ^[8] Medical Genomics Group Institute of Science and Technology Austria Klosterneuburg Austria. ^[9]

DOI 10.1002/dad2.12280

PMID 35475137

发布时间 2025-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Alzheimer's & dementia (Amsterdam, Netherlands)

2022年14卷1期

e12280页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Alzheimer's & dementia (Amsterdam, Netherlands)

2022年14卷1期

e12280页

检索历史清除

Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.

Alzheimer's & dementia (Amsterdam, Netherlands)

相似文献

同项目论文

Alzheimer's & dementia (Amsterdam, Netherlands)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.

Alzheimer's & dementia (Amsterdam, Netherlands)

相似文献

同项目论文

Alzheimer's & dementia (Amsterdam, Netherlands)

相关期刊

检索历史清除